Alexander S. Kuo

Reply: Liver transplantation in AH-ACLF-which condition drives post-transplant outcomes?

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: May 18, 2026

Assessing Major Adverse Liver Outcomes With Baclofen Compared to Acamprosate in Compensated Alcohol-Associated Cirrhosis.

Journal: Alimentary pharmacology & therapeutics

Published: November 16, 2025

Liver transplantation is the major determinant of ≥10-year survival in patients with hepatocellular carcinoma.

Journal: Hepatology communications

Published: September 23, 2025

Outcomes from Referral to Transplant for Patients with MASLD: A California Liver Network Study.

Journal: Journal of clinical medicine

Published: August 15, 2025

Recent Trends of Incidence, Mortality, Treatment, and Overall Survival of Hepatocellular Carcinoma in the United States.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: July 11, 2025

Liver Transplantation at the Extreme: Analysis of Outcomes and Predictors of Futility in Acute-on-Chronic Liver Failure Grade 3 Patients on Maximal Life Support.

Journal: JHEP reports : innovation in hepatology

Published: June 18, 2025

Workload, compensation, and institutional support among U.S. transplant hepatologists: Results of a national survey.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: May 27, 2025

Post-liver transplantation outcomes in acute-on-chronic liver failure: Impact of alcohol as a precipitant and etiology of chronic liver disease.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: April 01, 2025

Reply: Liver transplantation in AH-ACLF-which condition drives post-transplant outcomes?

Reply: Liver transplantation in AH-ACLF-which condition drives post-transplant outcomes?

Assessing Major Adverse Liver Outcomes With Baclofen Compared to Acamprosate in Compensated Alcohol-Associated Cirrhosis.

Assessing Major Adverse Liver Outcomes With Baclofen Compared to Acamprosate in Compensated Alcohol-Associated Cirrhosis.

Liver transplantation is the major determinant of ≥10-year survival in patients with hepatocellular carcinoma.

Liver transplantation is the major determinant of ≥10-year survival in patients with hepatocellular carcinoma.

Outcomes from Referral to Transplant for Patients with MASLD: A California Liver Network Study.

Outcomes from Referral to Transplant for Patients with MASLD: A California Liver Network Study.

Recent Trends of Incidence, Mortality, Treatment, and Overall Survival of Hepatocellular Carcinoma in the United States.

Recent Trends of Incidence, Mortality, Treatment, and Overall Survival of Hepatocellular Carcinoma in the United States.

Liver Transplantation at the Extreme: Analysis of Outcomes and Predictors of Futility in Acute-on-Chronic Liver Failure Grade 3 Patients on Maximal Life Support.

Liver Transplantation at the Extreme: Analysis of Outcomes and Predictors of Futility in Acute-on-Chronic Liver Failure Grade 3 Patients on Maximal Life Support.

Workload, compensation, and institutional support among U.S. transplant hepatologists: Results of a national survey.

Workload, compensation, and institutional support among U.S. transplant hepatologists: Results of a national survey.

Post-liver transplantation outcomes in acute-on-chronic liver failure: Impact of alcohol as a precipitant and etiology of chronic liver disease.

Post-liver transplantation outcomes in acute-on-chronic liver failure: Impact of alcohol as a precipitant and etiology of chronic liver disease.

Larsucosterol for the Treatment of Alcohol-Associated Hepatitis.

Larsucosterol for the Treatment of Alcohol-Associated Hepatitis.

Curative Treatment after Immunotherapy Leads to Excellent Outcomes in Patients with Hepatocellular Carcinoma.

Curative Treatment after Immunotherapy Leads to Excellent Outcomes in Patients with Hepatocellular Carcinoma.

Extracellular vesicle digital scoring assay for assessment of treatment responses in hepatocellular carcinoma patients.

Extracellular vesicle digital scoring assay for assessment of treatment responses in hepatocellular carcinoma patients.

Practical tips for delivering high impact live virtual lectures in interventional pain medicine.

Practical tips for delivering high impact live virtual lectures in interventional pain medicine.